To assess effects of el-adrenergic blockade on ventricular tachycardia (VT) of various mechanisms, electrophysiology studies were performed before and after intravenous infusion of propranolol (0.2 mg/kg) in 33 patients with chronic recurrent VT, who had previously been tested with intravenous verapamil (0.15 mg/kg followed by 0.005 mg/kg/min infusion). In the verapamil-irresponsive group, 10 patients (group IA) had VT that could be initiated by programmed ventricular extrastimulation and terminated by overdrive ventricular pacing, and 11 patients (group IB) had VT that could be provoked by isopro- (5) found that intravenous propranolol slowed the sinus rate but did not affect the VT rate and its inducibility. We and others (6-9), in contrast, observed that intravenous propranolol was effective in suppressing VT inducibility in patients in whom VT was provocable with intravenous infusion of isoproterenol. The disparity in responses to ,B-adrenergic blockade connotes that the occurrence of VT may be accounted for by different electrophysiologic mechanisms.
Introduction
To assess effects of el-adrenergic blockade on ventricular tachycardia (VT) of various mechanisms, electrophysiology studies were performed before and after intravenous infusion of propranolol (0.2 mg/kg) in 33 patients with chronic recurrent VT, who had previously been tested with intravenous verapamil (0.15 mg/kg followed by 0.005 mg/kg/min infusion). In the verapamil-irresponsive group, 10 patients (group IA) had VT that could be initiated by programmed ventricular extrastimulation and terminated by overdrive ventricular pacing, and 11 patients (group IB) had VT that could be provoked by isoproterenol infusion (3) (4) (5) (6) (7) (8) Ag/min) but not by programmed electrical stimulation, and that could not be converted to a sustained sinus rhythm by overdrive ventricular pacing. Notably, in the group IA patients, all 10 patients had structural heart disease (coronary arteriosclerosis or idiopathic cardiomyopathy); 8- adrenergic blockade accelerated the VT rate in one patient but exerted no effects on the VT rate in the remaining 9 patients, and VT remained inducible in all 10 patients. By contrast, in the group IB patients, 7 of the 11 patients had no apparent structural heart disease; 6-adrenergic blockade completely suppressed the VT inducibility during isoproterenol infusion in all 11 patients. There were 12 patients with verapamil-responsive VT (group II). 11 of the 12 patients had no apparent structural heart disease. In these patients, the initiation of VT was related to attaining a critical range of cycle lengths during sinus, atrial-paced or ventricular-paced rhythm; 8-adrenergic blockade could only slow the VT rate without suppressing its inducibility. Of note, 14 of the total 33 patients had exercise provocable VT: two in group IA, five in group IB, and seven in group II. Thus, mechanisms of VT vary among patients, and so do their pharmacologic responses. Although reentry, catecholamine-sensitive automaticity, and triggered activity related to delayed afterdepolarizations are merely speculative, results of this study indicate that ,8-adrenergic blockade is only specifically effective in a subset group (group IB) of patients with VT suggestive of catecholamine-sensitive automaticity.
j3-Adrenergic blockade exerts a multitude of metabolic, hemodynamic, and electrophysiologic effects and has been shown to be clinically efficacious in the treatment of certain forms of ventricular tachyarrhythmias (1) (2) (3) (4) . However, the mechanisms by which f3-adrenergic blockade suppresses ventricular tachyarrhythmias remain incompletely understood. In four patients with electrically inducible ventricular tachycardia (VT),' Wellens et al. (5) found that intravenous propranolol slowed the sinus rate but did not affect the VT rate and its inducibility. We and others (6) (7) (8) (9) , in contrast, observed that intravenous propranolol was effective in suppressing VT inducibility in patients in whom VT was provocable with intravenous infusion of isoproterenol. The disparity in responses to ,B-adrenergic blockade connotes that the occurrence of VT may be accounted for by different electrophysiologic mechanisms.
Using the technique of programmed electrical stimulation along with pharmacologic testing with intravenous verapamil, we have previously separated three "presumptive" mechanisms of VT in human beings: reentry, catecholamine-sensitive automaticity, and triggered activity related to delayed afterdepolarizations (10) . In the present study, we assessed effects of ,B-adrenergic blockade on these three forms ofVT. Our findings indicate that f3-adrenergic blockade is only specifically effective in suppressing VT suggestive of catecholamine-sensitive automaticity.
Methods
Patients. Between July 1983 and July 1986, we studied 33 patients with clinically documented sustained VT that could be reproduced during the course of electrophysiologic evaluation. Sustained VT was defined as VT that lasted longer than 30 s. We excluded patients who were hemodynamically unstable and who had a prior history of congestive heart failure or who had an ejection fraction of < 40% as measured by radionuclide angiography (1 1). All 33 patients had had echocardiography and treadmill exercise testing using the standard Bruce protocol (12) before electrophysiology studies. Additionally, 24 patients had undergone cardiac catheterization with coronary angiography as clinically indicated. There were 22 men and 11 women ranging in ages from 18 to 66 (mean 42.5) yr (Tables I-III) . 10 patients had arteriosclerotic heart disease with prior myocardial infarction of > 6 mo, 5 patients had idiopathic cardiomyopathy, and 18 patients had no clinical evidence of structural heart disease. All patients were clinically symptomatic with palpitations, dizziness, and/or syncope.
Plasma concentrations ofcatecholamines. In patients with VT provocable with treadmill exercise testing, blood samples were drawn for measurements of plasma epinephrine and norepinephrine levels Abbreviations: ASHD, arteriosclerotic heart disease; LBBB, left bundle branch block pattern; MI, myocardial infarction; RBBB, right bundle branch block pattern; TET, treadmill exercise testing; VT, ventricular tachycardia.
through an indwelling intravenous cannula (heparin lock) in a standing position at rest and at the stage of treadmill exercise testing during which VT was provoked. The normal ranges for plasma epinephrine and norepinephrine levels in a standing position at rest as measured by the high-pressure liquid chromatography (13) were, respectively, 32±9 and 256±68 pg/ml. Electrophysiology study. All patients gave informed consent, and all antiarrhythmic drugs were discontinued for at least five elimination half-lives before the study. The study was performed with patients in a postabsorptive, nonsedated state. With a conventional method (14) , a quadripolar electrode catheter was introduced from the right femoral vein and placed in the right atrioventricular junction for recording the His bundle potential. Two additional quadripolar electrode catheters were also introduced from the right femoral vein and, respectively, placed in the high right atrium and the right ventricle for electrical stimulation and recording intracardiac electrograms. All intracardiac electrograms were simultaneously displayed with electrocardiographic leads I, II, and VI on a multichannel oscilloscopic recorder (DR-16; Electronics for Medicine, White Plains, NY), and were recorded at a paper speed of 100 mm/s using filter frequency settings of 30-500 Hz.
A programmed digital stimulator (Bloom & Associates, Narberth, PA) was used to deliver electrical impulses of 2.0-ms duration at approximately twice diastolic threshold. During incremental pacing, the high right atrium and the right ventricle (apex and outflow tract) were, respectively, paced for 15-20 beats with abrupt cessation. We began pacing with a cycle length 20 ms shorter than that ofthe sinus rhythm. After each burst of pacing, we decreased the cycle length by 10-20 ms until the shortest pacing cycle length of 250 ms was reached.
During programmed extrastimulation, the high right atrium and the right ventricle (apex and outflow tract) were, respectively, driven at two cycle lengths (SI -SI) (usually 600 and 400 ms). An atrial and a ventricular premature beat (S2) were, respectively, introduced from late diastole at progressively shorter coupling interval (SI -S2) after every eighth drive beat until effective atrial and ventricular refractory periods were, respectively, encountered. To increase the sensitivity of VT induction, timed double and triple ventricular premature beats (S3 
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Abbreviations as in Table I . NAHD, no apparent heart disease.
(3-Adrenergic Blockade and Ventricular Tachycardia 689 Classification ofpatients. We realized that results of basic electrophysiologic studies are difficult to be extrapolated to explain findings of intact human hearts, and that there are practical limitations of electrophysiology study techniques (10, 16, 17) . Mechanisms of reentry, automaticity, and triggered activity related to delayed afterdepolarizations were applied (18) (19) (20) and patients were classified into two groups based on their responses to intravenous verapamil-verapamil-irresponsive (group I) and verapamil-responsive (group II).
Results
Before intravenous infusion of verapamil and propranolol, sustained VT with a QRS morphology identical to that occurred clinically could be reproduced during the control state in each patient. Among the 33 patients, intravenous verapamil infusion exerted no effects on the inducibility of VT in 21 patients (group I: verapamil-irresponsive) and totally suppressed the VT inducibility in 12 patients (group I1: verapamil-responsive).
Verapamil-irresponsive ventricular tachycardia (group I).
Based on the modes of VT initiation and termination, they were subdivided into groups IA and IB. Group IA patients had electrically inducible VT and group IB patients had VT that could not be induced electrically but was provocable with intravenous infusion of isoproterenol. There were 10 patients in group IA with ages ranging from 42 to 66 (mean 57.5) yr (Table I ). All of them had apparent structural heart disease: eight had arteriosclerotic heart disease with prior myocardial infraction and two had idiopathic cardiomyopathy. During electrophysiology studies, incremental atrial pacing, atrial extrastimulation, and incremental ventricular pacing did not elicit VT in any of them. However, programmed ventricular extrastimulation provoked sustained monomorphic VT that could be terminated by overdrive ventricular pacing in all 10 patients (Fig. 1 ). In 4 ofthe 10 patients, the initiation of VT required only single ventricular extrastimuli. Of these four patients, the interval between the initiating ventricular premature beat and the first beat of VT was inversely related to the premature coupling interval of ventricular extrastimuli (Fig. 1) . The rates of VT averaged 177 (150-200) beats/min, and QRS morphologies of VT were of a right bundle branch block pattern in seven patients and of a left bundle branch block pattern in three patients. In two patients (cases 4 and 9, Table I ) treadmill exercise testing provoked the onset of VT. After intravenous infusion of propranolol (0.2 mg/kg), VT remained inducible in all 10 patients. One patient (case 8, Table I ) manifested VT at a faster rate (increased from 170 to 220 beats/min) associated with symptomatic hypotension (blood pressure decreased from 1 10/70 to 70-80/50 mmHg) for which immediate overdrive ventricular pacing was necessary to terminate the arrhythmia. In the remaining 9 patients f3-adrenergic blockade did not affect the cycle length of VT. (Table II) . Seven patients had no apparent structural heart disease, two patients had idiopathic cardiomyopathy, and two patients had arteriosclerotic heart disease with prior myocardial infarction. All 11 patients had VT that could not be elicited by programmed atrial and programmed ventricular stimulation (Fig. 2, A and B) . The onset of VT required intravenous infusion of isoproterenol at 3-8 ,ug/min (Fig. 2 C) and overdrive ventricular pacing could not convert the arrhythmia to a sustained sinus rhythm. VT (Fig. 3) .
After f3-adrenergic blockade with intravenous propranolol (0.2 mg/kg), intravenous infusion of isoproterenol (3-8 gg/min) could no longer provoke an onset of the arrhythmia (Fig. 2 D) .
Verapamil-responsive ventricular tachycardia (group II (Fig. 4) . However, such a finding was not consistently observed in the remaining eight patients. Treadmill exercise testing provoked the onset of VT in 7 patients (cases 1, 2, 5, 6, 8, 9, and 10, Table III ). In all 12 patients, Bl-adrenergic blockade with intravenous propranolol infusion (0.2 mg/kg) invariably slowed the VT rate (cycle length lengthened 40-180 ms) without suppressing its inducibility (Fig. 6) ( Tables I-III) . None of them experienced chest pain or developed electrocardiographic ST-T changes diagnostic of acute myocardial ischemia or infarction before the onset of VT. The two patients in the group IA developed VT during stage I and the recovery phase, respectively. In the group IB, VT emerged during the stage III in two patients, during the stage IV in one patient, and during the recovery phase in two patients. In the group II, two patients developed VT during the stage I, three patients during the stage II, and two patients during the stage III.
The pacing cycle lengths ofprogrammed electrical stimulation were compared with those achieved during treadmill exercise testings in these 14 patients. In the two group IA and five group IB patients, the rates of incremental atrial and incremental ventricular pacing comparable to those at which VT was provoked during treadmill exercise testing were achieved, respectively, but failed to induce the arrhythmia (Figs. 2 and  3) . By contrast, in the seven group II patients, the rates of atrial-paced and/or ventricular-paced rhythm that initiated VT were comparable to those ofsinus tachycardia at which VT was provoked during treadmill exercise testing (Figs. 4-8 Hence, only in the group II patients with verapamil-responsive VT, was the initiation of VT a cycle length-dependent phenomenon.
In these 14 patients, plasma epinephrine and norepinephrine concentrations measured 38±8 (20-58) pg/ml and 246±65 (134-380) pg/ml, respectively, in the standing position at rest, which increased to 156±28 (69-222) pg/ml and 1,260±216 (692-2,330) pg/mi, respectively, at stages oftreadmill exercise testing during which VT was provoked. The resting values were within normal limits and those measured during treadmill exercise testing were comparable to the extent of exercise and did not appear excessive relative to what had been reported in the literature (21) .
Treadmill exercise testing could not be repeated with intra- TET stag 11 (control) B . TET stage 11 during Iv. verapaml Infusion Figure 7 . Verapamil-responsive VT tested with intravenous verapamil and intravenous propranolol (group II) (same patient as in Figs. 4-6 
Discussion
Rationalefor selection ofpatient population. The study was not intended to illustrate the incidence of VT of various electrophysiologic characteristics. There were two reasons why this particular cohort of 33 patients were selected for the study. First, intravenous verapamil and intravenous propranolol may, respectively, induce hypotension and/or precipitate congestive heart failure (22) at the prescribed doses. Therefore, patients with an ejection fraction of < 40% and/or a prior history of congestive heart failure were excluded. Second, VT mechanisms and responses to pharmacologic testings were considered more comparable when no severe left ventricular dysfunction was present in the whole cohort of 33 patients studied.
Effects of fl-adrenergic blockade on verapamil-irresponsive ventricular tachycardia (group I). Two distinctively different responses to fl-adrenergic blockade were observed between the group IA and group IB patients. In the former, VT was electrically inducible and fl-adrenergic blockade was totally ineffective in suppressing the VT inducibility; in the latter, VT was not electrically inducible but was provocable with intravenous isoproterenol infusion, and j3-adrenergic blockade could completely suppress the VT inducibility. Notably all 10 group IA patients had structural heart disease with coronary arteriosclerosis with prior myocardial infarction or idiopathic cardiomyopathy (Table I ). The QRS morphology of VT could be of either a right or a left bundle branch block pattern. The underlying mechanism of VT in this subset group of patients is generally believed to be due to reentry (23) . Ventricular extrastimulation is usually required for induction of unidirectional block in one area and slow conduction in the other area within the reentrant circuit (24) (25) (26) (27) , and overdrive ventricular pacing, by penetrating and altering refractoriness of the reentrant circuit, may thereby terminate the arrhythmia. Because of failure of this form of VT to respond to intravenous verapamil, we have previously hypothesized that the area of slow conduction associated with infarcted human ventricular myocardium is probably composed of depressed fast sodium channels rather than calcium channel-dependent slow responses (10) . This speculation is supported by the finding that, in diseased or infarcted ventricular myocardium, "poor responses" with slow conduction may be tetrodotoxin-sensitive rather than verapamil-sensitive (28, 29) .
Ofthe 11 group IB patients with VT provocable with intravenous isoproterenol infusion, only four of them had clinical evidence of structural heart disease. The QRS morphology of VT in this subset group of patients was predominantly ofa left bundle branch block pattern (Table II) . Isoproterenol is a (3-adrenergic agonist that enhances diastolic (phase 4) depolarization (18, 19) . We have previously postulated that this form of VT is caused by catecholamine-sensitive automaticity (10).
Intravenous propranolol, by competitively antagonizing stimulation of catecholamines at fl-adrenergic receptor sites, suppresses automatic VT provocability (30) with isoproterenol.
Two types of automaticity have been shown in animal Purkinje fibers: one which occurs at membrane potentials of around -90 mV referred to as "normal automaticity" and the other that occurs at membrane potentials of -40 to -60 mV referred to as "abnormal automaticity" (19, 31, 32) . In response to increasing rates and duration of overdrive pacing, normal automaticity may exhibit progressive postpacing cycle length lengthening, whereas abnormal automaticity usually appears nonsuppressible and may actually slightly increase in rate. The nonsuppressibility of abnormal automaticity with overdrive pacing is attributed to the assumption that a lesser degree of sodium entry was required for impulse generation as compared with that of normal automaticity (33) . Unfortunately, because of limitation of sites, rates, and duration of ventricular overdrive pacing, no attempt was made to distinguish these two types of automaticity in the present and our previous studies (10) .
Effects of fl-adrenergic blockade on verapamil-responsive ventricular tachycardia (group II). Patients with verapamil-responsive VT are relatively young and mostly had no clinical evidence of structural heart disease (10, (34) (35) (36) (37) (38) . Only one of the 12 group II patients had associated idiopathic cardiomyopathy (case 11, Table III ). Contrary to the claim of many investigators (34-37), verapamil-responsive VT is not confined to the QRS pattern of right bundle branch block with a superior frontal axis inasmuch as 5 of our 12 patients manifested a left bundle branch block pattern with a frontal axis varying from -750 to +1 100 (Table III) .
The initiation of this form of VT depends on the attainment of a critical range of cycle lengths (10, 38) . In most patients, the onset of VT can be initiated by straight atrial and straight ventricular pacing for -15-20 beats. In some patients, programmed ventricular extrastimulation can also trigger an onset of the arrhythmia. Of note, in 2 (cases 3 and 7, Table III) of our 12 patients, the VT initiation was only possible with incremental right ventricular pacing apparently because of concomitant development of atrioventricular nodal Wenckebach phenomenon during incremental right atrial pacing, which precluded attainment of the critical range of QRS cycle lengths (350-250 mis). In contrast, in the other two (cases 5 and 8, Table III ) patients, the initiation of VT was possible with incremental right atrial pacing but not with programmed right ventricular stimulation. In these latter two patients, failure to initiate VT during programmed ventricular stimulation (right ventricular apex and outflow tract) was ascribed to entrance block to the arrhythmia focus. Thus, programmed atrial or programmed right ventricular stimulation alone may not expose this form of VT. Moreover, the critical range of cycle lengths for the VT initiation can be as narrow as 20 ms. Careful scanning during incremental atrial and incremental ventricular pacing is essential for exposing verapamilresponsive VT.
The mechanism of verapamil-responsive VT is uncertain and debatable: reentry versus triggered activity related to delayed afterdepolarizations (10, (34) (35) (36) (37) (38) . Both reentry and triggered activity related to delayed afterdepolarizations are electrically inducible (23) (24) (25) (26) (27) (39) (40) (41) (42) (43) (44) (45) (46) (47) . For reasons given previously (10) , the interval between the initiating beat and the first beat of VT in response to the preceding pacing cycle length or premature coupling interval should not be construed as an accurate indicator for differential diagnosis. Reentry can be responsible for verapamil-responsive VT if the genesis of VT involves calcium channel-dependent slow responses in the reentrant circuit or is caused by active myocardial ischemia reversible with calcium channel blocking agents (48, 49) .
Under these circumstances, f3-adrenergic blockade slows the VT rate by decreasing the upstroke of slow response action potentials (50) or by counteracting a high adrenergic state which enhances myocardial conduction (51) . Nevertheless, none of our group II patients had clinical evidence of acute myocardial ischemia, and despite their younger average age as compared with the group IA patients, there was no clinical evidence of a higher adrenergic tone in the group II patients. In fact, the average rate of VT was significantly slower in the group II than the group IA patients (146.3 vs. 177 beats/min, P < 0.001) before fl-adrenergic blockade with intravenous propranolol.
Triggered activity resulting from delayed afterdepolarizations (39-47) remains a viable alternative mechanism. The initiation of triggered activity depends on previous depolarizations. Within a critical range of cycle lengths, delayed afterdepolarizations may attain threshold and elicit an action potential which, if perpetuated, can lead to a sustained rhythmic activity. The ionic currents responsible for the genesis of delayed afterdepolarizations are believed to be carried by sodium and modulated by calcium (52) (53) (54) . This hypothesis is supported by the finding that delayed afterdepolarizations are suppressible with calcium channel blockers (e.g., verapamil) and with high concentrations of the fast sodium channel blocker, tetrodotoxin (43, 44) . Overdrive stimulation enhances electrogenic sodium extrusion, and may thereby hyperpolarize the membrane potentials and prevent delayed afterdepolarizations from attaining threshold (55) . Hence, similar to reentry, triggered activity related to delayed afterdepolarizations can not only be initiated and but also be terminated by programmed electrical stimulation.
The stimulus-evoked transmembrane calcium entry is generally believed to be via the voltage-and time-dependent channels activated by depolarization and modulated via agonist-,B-adrenergic receptor interaction (56) . The mechanism by which 3-adrenergic stimulation increases the slow inward calcium current has been demonstrated to be mediated through the adenylate cyclase-cyclic AMP system (57-60).
Stimulation of f-adrenergic receptors promotes the conversion of cytosolic ATP to cyclic AMP. Cyclic AMP activates the cyclic AMP-dependent protein kinase which phosphorylates protein constituents of the membrane-bound calcium channels. Consequently, the availability of functioning slow inward calcium channels is increased. Verapamil directly blocks the voltage-and time-dependent slow inward calcium channels (56) and may also act as a competitive fl-adrenergic receptor antagonist (61) . On the other hand, by competitive inhibition, propranolol circumvents the stimulatory effects of f3-adrenergic agonists on the slow inward calcium current. It is tempting to postulate that verapamil-responsive VT caused by triggered activity related to delayed afterdepolarizations in our patients relies principally on the voltage-and time-dependent calcium channels with minimal dependence on agonist-fl-adrenergic receptor interaction. This assumption explains why verapamil could totally suppress the VT inducibility, and why propranolol could only slow the VT rate. Recently, Lerman et al. (62) described four patients with verapamil-responsive VT thought to be cyclic AMP-mediated triggered activity which was suppressible with intravenous propranolol. It may be that a diversity of biochemical and neurohormonal interactions are conducive to the genesis of verapamil-responsive VT.
Exercise-induced ventricular tachycardia. In the absence of acute myocardial ischemia or infarction, electrophysiologic mechanisms of exercise-induced VT vary among patients (8, 10) . The QRS morphology of VT is not predictive of the underlying mechanism as it can be either of a right or a left bundle branch block pattern (Tables I-111 ). The existence of different electrophysiologic mechanisms explains why exercise-induced VT is not uniformly responsive to any specific antiarrhythmic agent (7, 8, 63, 64) .
The finding that there was no excessive secretion of catecholamines at rest and during treadmill exercise testing in our 14 patients with exercise provocable VT is of interest. This inferred that the presence of a low sympathetic threshold and/ or an arrhythmia-prone anatomic substrate was responsible for the occurrence of VT. Although 9 ofthe 14 patients had no clinically demonstrable heart disease, the possibility of their having subclinical cardiac diseases such as healed myocarditis and/or cardiomyopathy could not be excluded with certainty (65, 66) .
Limitations of the study. There were practical limitations inherent to our study protocols. In using the induction of VT as the endpoint as outlined in the protocols, intravenous infusion of isoproterenol could be infused only in the group IB patients. Theoretically, isoproterenol can provoke VT of various mechanisms by exhibiting a variety of electrophysiologic effects. It enhances diastolic (phase 4) depolarization (18, 19) , decreases refractory periods of myocardial tissues (51, 67) , thereby allowing more degree of ventricular premature stimulation, and potentiates the development oftriggered activity by accelerating the sinus rate (shortening of cycle length) and increasing intracellular cyclic AMP (18-20, 40, 41, 57-60) . If the initiation of a reentrant arrhythmia or triggered rhythmic activity is solely dependent on intravenous infusion of isoproterenol, fl-adrenergic blockade with intravenous propranolol may be effective in suppressing the arrhythmia inducibility.
Furthermore, for near complete f3-adrenergic blockade, the dose of intravenous propranolol may require up to 0.6 mg/kg of body weight (68) . Such a high dose of intravenous propranolol may suppress VT of either reentry or triggered activity through inhibition ofthe depolarizing fast inward sodium current (69 
